Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Manufacturing · Pharmaceutical preparations
RARE price, last 12 months
Key stats
- Previous close
- $14.77
- Open
- $14.91
- Day range
- $14.15 – $14.94
- 52-week range
- $12.73 – $39.89
- Volume
- 3.8M
- Avg volume (20 days)
- 6.9M
- Market cap
- $1.4B
Performance
Technicals and fundamentals
About Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.4B